Thompson Davis & Co., Inc. Amgen Inc Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $19,888 - $22,760	-100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $18,529 - $20,889	100 New	100 $21,000
Q4 2017 Feb 05, 2018	SELL	$168.79 - $188.59 $27,850 - $31,117	-165 Closed	0 $0
Q3 2017 Oct 30, 2017	SELL	$167.29 - $191.0 $12,044 - $13,752	-72 Reduced 30.38%	165 $31,000
Q2 2017 Aug 10, 2017	BUY	N/A	237	237 $41,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.